Angiopoietin-1/Tie2 signaling pathway inhibits lipopolysaccharide-induced activation of RAW264.7 macrophage cells

Biochemical and Biophysical Research Communications

Volumn 392, Issue 2, 2010, Pages 178-182

  Gu, Huiping ^a   Cui, Ming ^a   Bai, Yun ^b   Chen, Fengrong ^a   Ma, Kangtao ^b   Zhou, Chunyan ^b   Guo, Lijun ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Angiopoietin 1; Inflammatory; Macrophage cells; NF B; Tie2 receptor

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOPOIETIN-1; ANIMALS; CELL LINE; HUMANS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NF-KAPPA B; PROTEIN TRANSPORT; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION;

EID: 75749145866     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.009     Document Type: Article

References (22)

1. Ziegler S.F., Bird T.A., Schneringer J.A., Schooley K.A., and Baum P.R. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 8 (1993) 663-670
2. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., and Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6 (2000) 460-463
3. Makinde T., and Agrawal D.K. Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease. J. Cell. Mol. Med. 12 (2008) 810-828
4. Brindle N.P., Saharinen P., and Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ. Res. 98 (2006) 1014-1023
5. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
6. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., and Yancopoulos G.D. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
7. Fiedler U., and Augustin H.G. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 27 (2006) 552-558
8. Kim I., Moon S.O., Park S.K., Chae S.W., and Koh G.Y. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ. Res. 89 (2001) 477-479
9. Witzenbichler B., Westermann D., Knueppel S., Schultheiss H.P., and Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111 (2005) 97-105
10. Mei S.H., McCarter S.D., Deng Y., Parker C.H., Liles W.C., and Stewart D.J. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 4 (2007) e269
11. Lucas A.D., and Greaves D.R. Atherosclerosis: role of chemokines and macrophages. Expert Rev. Mol. Med. 3 (2001) 1-18
12. Klemm S., and Ruland J. Inflammatory signal transduction from the Fc epsilon RI to NF-kappa B. Immunobiology 211 (2006) 815-820
13. Jeon B.H., Khanday F., Deshpande S., Haile A., Ozaki M., and Irani K. Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB. Circ. Res. 92 (2003) 586-588
14. Hughes D.P., Marron M.B., and Brindle N.P. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ. Res. 92 (2003) 630-636
15. Gamble J.R., Drew J., Trezise L., Underwood A., Parsons M., Kasminkas L., Rudge J., Yancopoulos G., and Vadas M.A. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87 (2000) 603-607
16. Kim I., Oh J.L., Ryu Y.S., So J.N., Sessa W.C., Walsh K., and Koh G.Y. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J. 16 (2002) 126-128
17. Liu W.K., Yen P.F., Chien C.Y., Fann M.J., Su J.Y., and Chou C.K. The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis. Biochem. J. 378 (2004) 867-876
18. Sturn D.H., Feistritzer C., Mosheimer B.A., Djanani A., Bijuklic K., Patsch J.R., and Wiedermann C.J. Angiopoietin affects neutrophil migration. Microcirculation 12 (2005) 393-403
19. Brkovic A., Pelletier M., Girard D., and Sirois M.G. Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation. J. Leukoc. Biol. 81 (2007) 1093-1101
20. Zhang L., and Chawla A. Role of PPARgamma in macrophage biology and atherosclerosis. Trends Endocrinol. Metab. 15 (2004) 500-505
21. Silverstein R.L. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve. Clin. J. Med. 76 Suppl. 2 (2009) S27-S30
22. Burger-Kentischer A., Goebel H., Seiler R., Fraedrich G., Schaefer H.E., Dimmeler S., Kleemann R., Bernhagen J., and Ihling C. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105 (2002) 1561-1566